Trade Summary

3 days ago, Saint Sean, serving as Pres, CEO at Beta Bionics, Inc. (BBNX), sold 3,384 shares at $12.36 per share, for a total transaction value of $41,832.00. Following this transaction, Saint Sean now holds 437,809 shares of BBNX.

This sale represents a 1.00% decrease in Saint Sean's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Monday, March 2, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, March 3, 2026, 1 day after the trade was made.

Beta Bionics, Inc. operates in the HEALTHCARE sector, specifically within the MEDICAL DEVICES industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.